Jump Financial, LLC Agios Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Oct 21, 2024
BUY
$19.97 - $24.53 $324,312 - $398,367
16,240 New
16,240 $361,000
Q4 2023

Feb 07, 2024
BUY
$19.97 - $24.53 $324,312 - $398,367
16,240 New
16,240 $361,000
Q4 2022

Feb 13, 2023
BUY
$24.81 - $31.52 $518,404 - $658,610
20,895 New
20,895 $586,000
Q2 2022

Aug 09, 2022
SELL
$17.06 - $31.42 $141,598 - $260,786
-8,300 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$26.68 - $34.81 $221,444 - $288,923
8,300 New
8,300 $242,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.89B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email